Categories: News

LivaNova to Host Conference Call for Second Quarter 2021 Results

LONDON–(BUSINESS WIRE)–#cardiovascular–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its second quarter 2021 results on Wednesday, July 28, 2021 at 1 p.m. London time (8 a.m. Eastern Daylight Time). The Company will release its second quarter 2021 results prior to the call.

A live audiocast of the conference call will be available on the Investors section of the LivaNova website at www.livanova.com. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. To listen to the conference call by telephone, dial 844-558-0159 (if dialing from within the U.S. or Canada) or 236-714-3182 (if dialing from outside the U.S. or Canada). The conference ID is 3308297. A replay will be available on the LivaNova website for 90 days following the call.

About LivaNova

LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 3,000 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide. For more information, please visit www.livanova.com.

Safe Harbor Statement

This news release contains “forward-looking statements” concerning our goals, beliefs, expectations, strategies, objectives, plans and underlying assumptions and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding our next conference call. Actual events may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2020, as supplemented by any risk factors contained in our Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K. We undertake no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.

Contacts

LivaNova Investor Relations and Media Contacts
Lindsey Little, +1 281-895-2382

Senior Director, Investor Relations

InvestorRelations@livanova.com

Deanna Wilke, +1 281-895-2382
VP, Corporate Communications

Corporate.Communications@livanova.com

Staff

Recent Posts

CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for…

1 hour ago

Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #earnings--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release…

1 hour ago

Waystar to Present at J.P. Morgan Healthcare Conference

LEHI, Utah and LOUISVILLE, Ky., Jan. 6, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY),…

1 hour ago

MARPAI ANNOUNCES SECOND TRANCHE OF NON-DILUTIVE GROWTH FUNDING WITH UP TO $5 MILLION FROM JGB

TAMPA, Fla., Jan. 6, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a…

1 hour ago

Mérieux NutriSciences Completes Acquisition of Bureau Veritas’ Food Testing Activities in Canada and the U.S.

CHICAGO, Jan. 6, 2025 /PRNewswire/ -- Mérieux NutriSciences, a world leader in food safety, quality, and…

1 hour ago

ImageTrend Acquires biospatial

LAKEVILLE, Minn., Jan. 6, 2025 /PRNewswire/ -- Today ImageTrend announces the purchase of biospatial, based…

1 hour ago